1. Home
  2. CXDO vs ACIU Comparison

CXDO vs ACIU Comparison

Compare CXDO & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.10

Market Cap

196.9M

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.34

Market Cap

229.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CXDO
ACIU
Founded
1995
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.9M
229.7M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
CXDO
ACIU
Price
$6.10
$2.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
★ $10.92
$8.57
AVG Volume (30 Days)
172.0K
★ 195.8K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 166.67
N/A
EPS
★ 0.05
N/A
Revenue
★ $68,167,000.00
N/A
Revenue This Year
$42.60
$422.39
Revenue Next Year
$13.69
$377.85
P/E Ratio
$123.60
★ N/A
Revenue Growth
★ 12.05
N/A
52 Week Low
$5.35
$2.03
52 Week High
$11.23
$3.90

Technical Indicators

Market Signals
Indicator
CXDO
ACIU
Relative Strength Index (RSI) 58.62 41.75
Support Level $5.96 $2.13
Resistance Level $6.71 $2.41
Average True Range (ATR) 0.25 0.11
MACD 0.06 -0.01
Stochastic Oscillator 88.49 64.65

Price Performance

Historical Comparison
CXDO
ACIU

About CXDO Crexendo Inc.

Crexendo Inc is a software technology company that provides cloud communication platform software and unified communications as a service (UCaaS) offering, including voice, video, contact center, and managed IT services. The company operates through two segments: Cloud Telecommunications Services and Software Solutions. Its cloud telecommunications segment generates revenue from the provision of broadband Internet services, managed IT services, software license sales, and infrastructure as a service. The software solutions segment derives revenues from three primary sources: software licenses, software maintenance support and professional services. The majority of the company's revenue is derived from the Cloud Telecommunications Services segment.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: